Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Patriot Scientific Corporation Releases First Fiscal Quarter Report

This sounds promising:

Despite our litigation with TPL, we have been engaged in ongoing discussions in an attempt to achieve a resolution to our differences," stated Cliff Flowers, Patriot's interim CEO. "Our objective has been to secure an agreement that paves the way for the continuation of licensing revenues, while ensuring that Patriot and its shareholders are fairly compensated for their ownership interests in the Moore Microprocessor Patent Portfolioâ„¢. We have been pursuing the dual path of negotiating and litigating, aggressively preserving our full range of options in furtherance of our objectives, and will provide further information as definitive events take place."

Share
New Message
Please login to post a reply